0001781002-20-000032.txt : 20200528
0001781002-20-000032.hdr.sgml : 20200528
20200528182938
ACCESSION NUMBER: 0001781002-20-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200526
FILED AS OF DATE: 20200528
DATE AS OF CHANGE: 20200528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bleichroeder LP
CENTRAL INDEX KEY: 0001781002
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31615
FILM NUMBER: 20923088
BUSINESS ADDRESS:
STREET 1: 1345 AVENUE OF THE AMERICAS
STREET 2: 47TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10105
BUSINESS PHONE: 917-769-2999
MAIL ADDRESS:
STREET 1: 1345 AVENUE OF THE AMERICAS
STREET 2: 47TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DURECT CORP
CENTRAL INDEX KEY: 0001082038
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943297098
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10260 BUBB RD
CITY: CUPERTINO
STATE: CA
ZIP: 95014
BUSINESS PHONE: 4087771417
MAIL ADDRESS:
STREET 1: 10260 BUBB ROAD
CITY: CUPERTINO
STATE: CA
ZIP: 95014
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-05-26
0
0001082038
DURECT CORP
DRRX
0001781002
Bleichroeder LP
1345 AVENUE OF THE AMERICAS
47TH FLOOR
NEW YORK
NY
10105
0
0
1
0
Common Stock
2020-05-26
4
S
0
39388
2.5014
D
26664656
I
See Footnote
The transaction reported herein was entered into in error. In addition, the sale by the reporting person of 39,388 shares of Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase by the reporting person of 39,388 shares of the Issuer's common stock on February 6, 2020 as reported in a prior Form 4 filing. Pursuant to a settlement agreement with the Issuer, the reporting person has paid to the issuer $34,588.00, representing the full amount of the profit realized in connection with the short-swing transaction.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions. Prices ranged from $2.50 to $2.511 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This form is filed by Bleichroeder LP. Bleichroeder LP serves as registered investment adviser to 21 April Fund, Ltd., 21 April Fund, LP and other managed accounts that directly hold these securities. Bleichroeder LP disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that Bleichroeder LP is the beneficial owner of the securities for purposes of Section 16 or for any other purposes. 21 April Fund, Ltd. owns 16,036,514 shares and 21 April Fund, LP owns 4,718,700 shares respectively of these 26,664,656 shares reported in this form.
Michael M. Kellen, Chairman and CO-CEO of Bleichroeder LP
2020-05-28